BDBM37570 2-chloranyl-6-fluoranyl-N-[(5-phenacylsulfanyl-1,3,4-oxadiazol-2-yl)methyl]benzamide::2-chloro-6-fluoro-N-({5-[(2-oxo-2-phenylethyl)thio]-1,3,4-oxadiazol-2-yl}methyl)benzamide::2-chloro-6-fluoro-N-[(5-phenacylsulfanyl-1,3,4-oxadiazol-2-yl)methyl]benzamide::2-chloro-6-fluoro-N-[[5-(phenacylthio)-1,3,4-oxadiazol-2-yl]methyl]benzamide::MLS000091591::SMR000026142::cid_3243696

SMILES Fc1cccc(Cl)c1C(=O)NCc1nnc(SCC(=O)c2ccccc2)o1

InChI Key InChIKey=MYOVEBZFTFNEFG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37570   

TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37570(2-chloranyl-6-fluoranyl-N-[(5-phenacylsulfanyl-1,3...)
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In DepthDetails PCBioAssay